Literature DB >> 24102226

Vestibular evoked myogenic potential according to middle ear condition in chronic otitis media with tympanic membrane perforation.

Jun Seok Lee1, Sun Kyu Lee, Il Ho Shin, Seung Geun Yeo, Moon Suh Park, Jae Yong Byun.   

Abstract

CONCLUSION: Vestibular evoked myogenic potential (VEMP) function results can vary between individuals with different middle ear conditions. Therefore, by analyzing VEMP results after paper patching, we can predict the condition of the middle ear in chronic otitis media (COM) patients.
OBJECTIVES: VEMP responses decrease with impairment of sound transmission, such as in conductive hearing loss (CHL). COM with tympanic membrane (TM) perforation is a common disorder that causes various degrees of CHL. The aim of this study was to evaluate and clarify the VEMP responses in patients with COM with different middle ear pathology.
METHODS: This study included 50 patients with unilateral COM with TM perforation. Initial pure-tone audiometry (PTA) and VEMP responses were recorded. After paper patching, PTA and VEMP were re-performed. Each VEMP response was compared with those of the healthy controls. Moreover, VEMP responses between pre- and post-paper patching were compared.
RESULTS: There was a positive correlation between normalizing of VEMP parameters, such as p13 and VEMP asymmetry ratio (VAR), and reduction of air-bone gap in patients with COM after paper patching. The VEMP response in patients with COM with intact ossicle and clean mucosa was more normalized compared with those in patients with COM with different middle ear conditions.

Entities:  

Mesh:

Year:  2013        PMID: 24102226     DOI: 10.3109/00016489.2013.836756

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  1 in total

1.  Evaluation of ocular and cervical vestibular evoked myogenic potentials in a conductive hearing loss model.

Authors:  Peng Han; Rui Zhang; Zichen Chen; Ying Gao; Ying Cheng; Qing Zhang; Min Xu
Journal:  J Otol       Date:  2017-01-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.